You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

onartuzumab

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in Worldwide (Onartuzumab, Bevacizumab, Erlotinib)

Completed
Has Results
  • Solid Tumor
  • Onartuzumab
  • +2 more
  • Lille, France
  • +9 more
Jul 18, 2019

Glioblastoma Trial in Worldwide (Bevacizumab, Onartuzumab, Placebo)

Completed
  • Glioblastoma
  • Birmingham, Alabama
  • +61 more
Feb 2, 2018

Tumors Trial in United States (Cobimetinib, Onartuzumab, Vemurafenib)

Withdrawn
  • Neoplasms
  • Los Angeles, California
  • +5 more
Nov 1, 2016

Carcinoma, Hepatocellular Trial in Worldwide (Onartuzumab, Sorafenib)

Completed
  • Carcinoma, Hepatocellular
  • Sarasota, Florida
  • +9 more
Nov 1, 2016

Breast Cancer Trial in Worldwide (Onartuzumab, Bevacizumab, Paclitaxel)

Completed
  • Breast Cancer
  • Onartuzumab
  • +4 more
  • Bakersfield, California
  • +52 more
Jan 19, 2017

Non-Squamous NSCLC Trial in Worldwide (erlotinib, onartuzumab, )

Completed
  • Non-Squamous Non-Small Cell Lung Cancer
  • Bakersfield, California
  • +34 more
Nov 1, 2016

Gastric Cancer Trial in Worldwide (5-Fluoruracil, Folinic acid, Onartuzumab)

Completed
  • Gastric Cancer
  • Los Angeles, California
  • +124 more
Nov 1, 2016

Non-Squamous NSCLC Trial in Worldwide (Placebo, cisplatin/carboplatin, onartuzumab)

Completed
  • Non-Squamous Non-Small Cell Lung Cancer
  • Placebo
  • +3 more
  • Huntsville, Alabama
  • +68 more
Sep 1, 2016

Lung Cancer Trial in Houston (Onartuzumab, Erlotinib, Paclitaxel)

Withdrawn
  • Lung Cancer
  • Onartuzumab
  • +4 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 22, 2014